Limits...
A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States.

Cohen J, Collins R, Darkes J, Gwartney D - J Int Soc Sports Nutr (2007)

Bottom Line: The majority of respondents did not initiate AAS use during adolescence and their NMAAS use was not motivated by athletics.These findings question commonly held views of the typical NMAAS user and the associated underlying motivations.The focus on "cheating" athletes and at risk youth has led to ineffective policy as it relates to the predominant group of NMAAS users.

View Article: PubMed Central - HTML - PubMed

Affiliation: Collins, McDonald & Gann, P,C,, Carle Place, NY, USA. rcollins@cmgesq.com.

ABSTRACT

Background: Rule violations among elite-level sports competitors and tragedies among adolescents have largely defined the issue of non-medical anabolic-androgenic steroid (NMAAS) use for the public and policy makers. However, the predominant and oft-ignored segment of the NMAAS community exists in the general population that is neither participating in competitive sports nor adolescent. A clearer profile of NMAAS users within the general population is an initial step in developing a full understanding of NMAAS use and devising appropriate policy and interventions. This survey sought to provide a more comprehensive profile of NMAAS users by accessing a large sample of user respondents from around the United States.

Methods: U.S.-based male NMAAS users (n = 1955) were recruited from various Internet websites dedicated to resistance training activities and use of ergogenic substances, mass emails, and print media to participate in a 291-item web-based survey. The Internet was utilized to provide a large and geographically diverse sample with the greatest degree of anonymity to facilitate participation.

Results: The majority of respondents did not initiate AAS use during adolescence and their NMAAS use was not motivated by athletics. The typical user was a Caucasian, highly-educated, gainfully employed professional approximately 30 years of age, who was earning an above-average income, was not active in organized sports, and whose use was motivated by increases in skeletal muscle mass, strength, and physical attractiveness. These findings question commonly held views of the typical NMAAS user and the associated underlying motivations.

Conclusion: The focus on "cheating" athletes and at risk youth has led to ineffective policy as it relates to the predominant group of NMAAS users. Effective policy, prevention or intervention should address the target population(s) and their reasons for use while utilizing their desire for responsible use and education.

No MeSH data available.


Typical Daily Methandrostenolone Dosage.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2131752&req=5

Figure 8: Typical Daily Methandrostenolone Dosage.

Mentions: Reports of use and effectiveness ratings while considering side effects were obtained for 15 AAS agents. Single ester testosterones, methandrostenolone, and nandrolone decanoate were the most commonly used agents and single and multi-ester testosterones and trenbolone were rated most effective/useful (see Figure 6. Average total AAS dosages ranged from <200 mg (n = 59, 3.6%) to more then 5,000 mg/week (n = 2, 0.1%) with an average of 500–1000 mg/week. The highest dosage of testosterone used for four or more weeks had considerable variability with an average dosage of 797.5 mg/week (sd = 540.11, range = <200 to 10,000 mg/week). Typical weekly testosterone and methandrostenolone dosages are listed in Figures 7 and 8 respectively.


A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States.

Cohen J, Collins R, Darkes J, Gwartney D - J Int Soc Sports Nutr (2007)

Typical Daily Methandrostenolone Dosage.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2131752&req=5

Figure 8: Typical Daily Methandrostenolone Dosage.
Mentions: Reports of use and effectiveness ratings while considering side effects were obtained for 15 AAS agents. Single ester testosterones, methandrostenolone, and nandrolone decanoate were the most commonly used agents and single and multi-ester testosterones and trenbolone were rated most effective/useful (see Figure 6. Average total AAS dosages ranged from <200 mg (n = 59, 3.6%) to more then 5,000 mg/week (n = 2, 0.1%) with an average of 500–1000 mg/week. The highest dosage of testosterone used for four or more weeks had considerable variability with an average dosage of 797.5 mg/week (sd = 540.11, range = <200 to 10,000 mg/week). Typical weekly testosterone and methandrostenolone dosages are listed in Figures 7 and 8 respectively.

Bottom Line: The majority of respondents did not initiate AAS use during adolescence and their NMAAS use was not motivated by athletics.These findings question commonly held views of the typical NMAAS user and the associated underlying motivations.The focus on "cheating" athletes and at risk youth has led to ineffective policy as it relates to the predominant group of NMAAS users.

View Article: PubMed Central - HTML - PubMed

Affiliation: Collins, McDonald & Gann, P,C,, Carle Place, NY, USA. rcollins@cmgesq.com.

ABSTRACT

Background: Rule violations among elite-level sports competitors and tragedies among adolescents have largely defined the issue of non-medical anabolic-androgenic steroid (NMAAS) use for the public and policy makers. However, the predominant and oft-ignored segment of the NMAAS community exists in the general population that is neither participating in competitive sports nor adolescent. A clearer profile of NMAAS users within the general population is an initial step in developing a full understanding of NMAAS use and devising appropriate policy and interventions. This survey sought to provide a more comprehensive profile of NMAAS users by accessing a large sample of user respondents from around the United States.

Methods: U.S.-based male NMAAS users (n = 1955) were recruited from various Internet websites dedicated to resistance training activities and use of ergogenic substances, mass emails, and print media to participate in a 291-item web-based survey. The Internet was utilized to provide a large and geographically diverse sample with the greatest degree of anonymity to facilitate participation.

Results: The majority of respondents did not initiate AAS use during adolescence and their NMAAS use was not motivated by athletics. The typical user was a Caucasian, highly-educated, gainfully employed professional approximately 30 years of age, who was earning an above-average income, was not active in organized sports, and whose use was motivated by increases in skeletal muscle mass, strength, and physical attractiveness. These findings question commonly held views of the typical NMAAS user and the associated underlying motivations.

Conclusion: The focus on "cheating" athletes and at risk youth has led to ineffective policy as it relates to the predominant group of NMAAS users. Effective policy, prevention or intervention should address the target population(s) and their reasons for use while utilizing their desire for responsible use and education.

No MeSH data available.